| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 93.21B | 91.14B | 90.56B | 92.30B | 80.52B | 68.41B |
| Gross Profit | 12.68B | 12.16B | 10.35B | 10.84B | 11.08B | 10.67B |
| EBITDA | 7.12B | 10.19B | 9.67B | 10.13B | 12.38B | 8.18B |
| Net Income | 5.83B | 5.55B | 6.06B | 7.38B | 9.92B | 5.29B |
Balance Sheet | ||||||
| Total Assets | 237.22B | 223.19B | 225.39B | 221.07B | 222.82B | 204.80B |
| Cash, Cash Equivalents and Short-Term Investments | 32.97B | 32.94B | 31.75B | 31.52B | 33.27B | 29.40B |
| Total Debt | 87.72B | 84.60B | 84.57B | 78.24B | 72.96B | 69.37B |
| Total Liabilities | 125.85B | 119.32B | 122.56B | 118.03B | 113.76B | 107.38B |
| Stockholders Equity | 96.46B | 90.32B | 89.11B | 89.92B | 95.98B | 84.90B |
Cash Flow | ||||||
| Free Cash Flow | 3.48B | 600.16M | -575.29M | -4.54B | 48.19M | 4.25B |
| Operating Cash Flow | 8.16B | 7.14B | 9.18B | 8.88B | 11.55B | 10.44B |
| Investing Cash Flow | -3.38B | -7.11B | -11.74B | -14.34B | -11.34B | -6.04B |
| Financing Cash Flow | -7.92B | 465.89M | 3.63B | 2.36B | 1.81B | 1.03B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | HK$22.41B | 2.84 | 6.12% | 5.00% | 2.39% | 7.81% | |
68 Neutral | HK$381.08B | 5.51 | 5.53% | 5.15% | 2.24% | 1.42% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | HK$252.59B | 17.13 | 2.12% | 4.02% | -0.47% | -30.71% | |
60 Neutral | HK$40.05B | 7.30 | 5.66% | 4.94% | 3.77% | -1.53% | |
56 Neutral | HK$16.78B | 7.75 | 4.07% | 6.37% | -27.96% | -28.06% | |
42 Neutral | HK$33.62B | -1.40 | -21.69% | 0.44% | -9.73% | -440.87% |